BioSpace News Archive

FDA

Novo Nordisk Wins Expanded Approval for Victoza in Youth With Type 2 Diabetes

The approval marks the first glucagon-like peptide-1 (GLP-1) receptor agonist approved for children and adolescents with type 2 diabetes.

June 18, 2019
·
2 min read
·
Alex Keown
Policy

Singapore Scientists Discover New Viruses That Identifies High-Risk Individuals Of Cantonese Cancer

Scientists from the Agency for Science, Technology and Research’s Genome Institute of Singapore have identified two new Epstein-Barr Virus viral variants associated with cancers, including nasopharyngeal carcinoma, gastric cancer, and several kinds of lymphomas[2].

June 18, 2019
·
6 min read
Drug Development

Amarantus Announces Positive Pre-Clinical Data for MANF in Wolfram Syndrome Presented at the 79th Annual Scientific Sessions of the American Diabetes Association

Amarantus Bioscience Holdings, Inc. announced that positive results from in vitro and animal studies on MANF in the treatment of Wolfram Syndrome were presented at the 79th Annual Scientific Sessions of the American Diabetes Association.

June 18, 2019
·
5 min read
Job Trends

Pushing the Bounds of Memory

A University of Houston researcher is examining the reaction in the brain at the precise moment when certain memories are seared into our minds.

June 18, 2019
·
2 min read
New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome

Minimally-invasive blood test could complement colonoscopy in high-risk LS patients who are non-compliant with colonoscopy screening recommendations or may develop precancerous lesions in the interval between colonoscopies

June 18, 2019
·
7 min read
Business

Roger Frechette, Ph.D., Joins Akelos Inc., as Director of Operations & Business Development

Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds Dr. Roger Frechette to its Executive Team as Director of Operations & Business Development.

June 18, 2019
·
2 min read
Roche’s Rozlytrek Hits Milestone with Approval in Japan

Rozlytrek is the first tumor-agnostic medicine approved in Japan for adult and pediatric patients with NTRK fusion-positive advanced recurrent solid tumors.

June 18, 2019
·
3 min read
·
Alex Keown
Business

The Importance of Increasing Diversity in Genetic Research

The advent of increasingly more mainstream and affordable genetic testing enables powerful genetic research – but that power is directly associated with the strength and diversity of the database of genetic information available.

June 18, 2019
·
6 min read
·
Chelsea Weidman Burke
Business

Synergy™ and Cytation™ Readers Validated for Agilent MitoXpress and pH-Xtra Assays

BioTek is pleased to announce that its Synergy™ H1 and Synergy Neo2 Hybrid Multi-Mode Readers and its Cytation™ 1 and Cytation 5Cell Imaging Multi-Mode Readers are validated for use with the MitoXpress and pH-XtraAssays from Agilent Technologies.

June 18, 2019
·
1 min read
Cancer-killing virus boosts immunotherapy in hard-to-treat cancer

Combining a cancer-killing virus with immunotherapy could effectively treat advanced cancers that affect the limbs, a new study reveals.

June 18, 2019
·
6 min read